PROJECT DESCRIPTION
References
- Centers for Disease Control and Prevention [Internet]. 2013. Antibiotic Resistance Threats in the United States [cited 2016 September 23]. Web.
- Parmley S. Programmable sensitivity. Sci-BX. 2014;7(41):2012–2014. Web.
- Yosef I, Kiro R, Molshanski-Mor S, Edgar R, Qimron U. Different approaches for using bacteriophages against antibiotic-resistant bacteria. Bacteriophage. 2014;4(1):e28491. Web.
- Suda T, Liu D. Hydrodynamic gene delivery: its principles and applications. Mol Ther. 2007;15(12):2063–2069. Web.
- Zuris JA, Thompson DB, Shu Y, Guilinger JP, Bessen JL, Hu JH, Maeder ML, Joung JK, Chen ZY , Liu DR. Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo. Nat Biotechnol, 2014;33(1):73–80. Web.
- McBroom AJ, Kuehn MJ. Outer Membrane Vesicles. EcoSal Plus. 2005. Web.
- Yamamoto Y, Harashima A, Saito H, Tsuneyama K, Munesue S, Motoyoshi S, Han D, Watanabe T, Asano M, Takasawa S, Okamoto H, Shimura S, Karasawa T, Yonekura H, Yamamoto H. Septic Shock Is Associated with Receptor for Advanced Glycation End Products Ligation of LPS. The Journal of Immunology. 2011;186(5): 3248-3257. Web.
- Mamat U, Woodard RW, Wilke K, Souvignier C, Mead D, Steinmetz E, Terry K, Kovacich C, Zegers A, Knox C. Endotoxin-free protein production—ClearColi™ technology. Nature Methods. 2013. Web.
